Short-term anticoagulation before electrical cardioversion of chronic atrial fibrillation;Anticoagulazione e cardioversione elettrica della fibrillazione atriale cronica: Proposta di un protocollo abbreviato

Giornale Italiano di Cardiologia

Volumn 27, Issue 8, 1997, Pages 803-810

  Antonielli, Emanuele ^a,d   Pizzuti, Alfredo ^a   Gandolfo, Nicola ^b   Sclavo, Mariagrazia ^c   Tanga, Mattia ^a   Riva, Giuseppe ^a   Leonardi, Giovanni ^a   Bassignana, Antonia ^a   Di Leo, Margherita ^a  

^a Ospedale SS Annunziata   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c S GIOVANNI BOSCO HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

Atrial; Cardioversion; Fibrillation; Trensesophageal echocardiography; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; MALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; CLINICAL PROTOCOLS; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; WARFARIN;

EID: 0030871290     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. KANNELL WB, ABBOTT RD, SAVAGE DD, MCNAMARA PM: Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-1022.
2. PETERSEN P, BOYSEN G, GODTFREDSEN J, ANDERSEN ED, ANDERSEN B: Placebo-controlled randomized trial of warfarin and aspirin for the prevention of thromboembolic complication in chronic atrial fibrillation: the Copenaghen AFASAK study. Lancet 1989; 1: 175-179.
3. THE BOSTON AREA ANTICOAGULATION TRIAL FOR ATRIAL FIBRILLATION INVESTIGATORS: The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-1511.
4. STROKE PREVENTION IN ATRIAL FIBRILLATION STUDY GROUP INVESTIGATORS: Preliminary report of the stroke prevention in atrial fibrillation. N Engl J Med 1990; 322: 863-868.
5. HURST JW, FAULK FA JR, PROCTOR HD, SCHLANT RC: Management of patients with atrial fibrillation. Am J Med 1964: 728-741.
6. HANSEN WR, MCCLENDON RO, KINSMAN JM: Auricolar fibrillation: hemodynamic studies before and after conversion with quinidine. Am Heart J 1952; 44: 499-516.
7. LIPKIN DP, FRENNEAUX M, STEWART R, JOSHI J, LOWE T, MCKENNA WJ: Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to synus rhythm. Br Heart J 1988; 59: 572-577.
8. ATWOOD JE, MYERS J, SULLIVAN M, ET AL: The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am Heart J 1989; 118: 913-918.
9. THOMSON GW: Quinidine as a cause of sudden death. Circulation 1956; 14: 757-765.
10. LOWN B, PERLROTH MG, KAIDBEY S, ABE T, HARKEN DI: "Cardioversion" of atrial fibrillation: a report on treatment of 65 episodes in 50 patients. N Engl J Med 1963; 269: 325-331.
11. RESNEKOV L, MCDONALD L: Complications in 220 patients with cardiac dysrhythmias treat-ed by phased direct current shock, and indication for electroversion. Br Heart J 1967; 29: 926-935.
12. WEINBERG DM, MANCINI GBJ: Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 745-746.
13. ARNOLD AZ, MICH MJ, MAZURECK RP, LOOP FD, TROHMAN RG: Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992; 19: 851-855.
14. BJERKELUND CJ, ORNING OM: The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969; 23: 208-216.
15. LAUPACIS A, ALBERS G, DUNN M, FEINBERG W: Antithrombotic therapy in atrial fibrillation. Third ACCP Conference on Antithrombotic Therapy. Chest 1992; 102: 426S-433S.
16. WEINBERG DM, MANCINI GBJ: Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 745-746.
17. COON WW, WILLIS PW: Hemorrhagic complications of anticoagulant therapy. Arch Intern Med 1974; 133: 386-392.
18. MANNING WJ, SILVERMAN DI, GORDON SPF, KRUMHOLZ HM, DOUGLAS PS: Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993; 328: 750-755.
19. GRIMM RA, STEWART WJ, BLACK IW, THOMAS JD, KLEIN AL: Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation? J Am Coll Cardiol 1994; 23: 533-541.
20. MANNING WJ, SILVERMAN DI, KEIGHLEY CS, OETTGEN P, DOUGLAS PS: Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol 1995; 25: 1354-1361.
21. ASCHENBERG W, SCHLUTER M, KREMER P, SCHRODER E, SIGLOW V, BLEIFELD W: Transesophageal two-dimensional echocardiography for the detection of left atrial thrombi. J Am Coll Cardiol 1986; 7: 163-166.
22. OLSON JP, GOLDENBERG IF, PEDERSON W, ET AL: Exclusion of atrial thrombus by transesophageal echocardiography. J Am Soc Echocardiogr 1992; 5: 52-56.
23. CHAN M, MARCUS R, BEDNARZ J, CHILDERS R, LANG R: Contribution of transesophageal echocardiography to cardioversion protocols for atrial fibrillation (abstract). J Am Soc Echocardiogr 1992; 5: 308 .
24. STODDARD MF, LONGAKER RA: Role of transesophageal echocardiography prior to cardioversion in patients with atrial fibrillation (abstract). J Am Coll Cardiol 1993; 21: 28A.
25. ORSINELLI DA, PALNIK N, PEARSON AC: Utility of transesophageal echocardiography in screening for the presence of left atrial thrombus prior to elective cardioversion for atrial fibrillation (abstract). J Am Soc Echocardiogr 1992; 5: 308.
26. BLACK IW, HOPKINS AP, LEE LCL, WALSH WF: Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993; 126: 375-381.
27. BLACK IW, FATKIN D, SAGRA KB, ET AL: Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89: 2509-2513.
28. ANTONIELLI E, PIZZUTI A, GANDOLFO N, ET AL: L'ecocardiografia transesofagea nei pazienti in fibrillazione atriale candidati a cardioversione: utilità e limiti. G Ital Cardiol 1995; 25: 543-552.
29. HWANG JJ, CHEN JJ, LIN SC, ET AL: Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations. Am J Cardiol 1993; 72: 677-681.
30. GRIMM RA, STEWART WJ, MALONEY JD, ET AL: Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993; 22: 1359-1366.
31. FATKIN D, KUCHAR DL, THORNBURN CW, FENELEY MP: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23: 307-316.
32. KINCH FW, DAVIDOFF R: Prevention of embolic events after cardioversion of atrial fibrillation. Arch Intern Med 1995; 155: 1353-1360.
33. DETHY M, CHASSAT C, ROY D, MERCIER LA: Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion. Am J Cardiol 1988; 62: 723-726.
34. DITTRICH HC, ERICKSON JS, SCHNEIDERMAN T, BLACKY AR, SAVIDES T, NICOD PH: Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193-197.
35. MANNING WJ, SILVERMAN DI, KATZ SE, ET AL: Impaired left atrial mechanical function after cardioversion: relationship to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23: 1535-1540.
36. KLEIN AL, GRIMM RA, BLACK IW, ET AL: Cost effectiveness of TEE-guided cardioversion with anticoagulation compared to conventional therapy in patients with atrial fibrillation (abstract). J Am Coll Cardiol 1994; 24: 128A.
37. ORSINELLI DA, PEARSON AC: Usefulness of transesophageal echocardiography to screen for left atrial thrombus before selective cardioversion for atrial fibrillation. Am J Cardiol 1993; 72: 1337-1339.
38. STODDARD MF, DAWKINS PR, PRINCE CR, LONGAKER RA: Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995; 129: 1204-1215.
39. PEVERILL RE, HARPER RW, GELMAN J, ENG GAN T: Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. Circulation 1996; 94: 331-339.
40. WANG XF, LIU L, CHENG TO, LI ZA, DENG YB, WANG JE: The relationship between intracardiovascular smoke-like echo and erythrocyte rouleaux formation. Am Heart J 1992; 124: 961-965.
41. FATKIN D, KELLY RP, FENELEY MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
42. POZZOLI M, FEBO O, TORBICKI A, ET AL: Left atrial appendage dysfunction: a cause of thrombosis? Evidence by transesophageal echocardiography-doppler studies. J Am Soc Echocardiogr 1991; 4: 435-441.
43. SCARDI S, PANDULLO C, MAZZONE C, GOLDSTEIN D, ZECCHIN M: La stratificazione del rischio tromboembolico nei pazienti con fibrillazione atriale non reumatica: il contributo della disfunzione auricolare sinistra. G Ital Cardiol 1996; 26: 273-285.
44. COLLIN LJ, SILVERMAN DI, DOUGLAS PS, MANNING WJ: Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995; 92: 156-159.
45. HIRSH J: Oral anticoagulant drugs. N Eng J Med 1991; 324: 1865-1875.
46. VIGANÒ S, MANNUCCI PM, SOLINAS S, BOTTASSO B, MARIANI G: Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy. Br J Haematol 1984; 57: 213-220.
47. PEARSON AC: Transesophageal echocardiographic screening for atrial thrombus before cardioversion of atrial fibrillation: when should we look before we leap? J Am Coll Cardiol 1995; 25: 1362-1364.
48. STODDARD MF, DAWKINS PR, PRINCE CR, AMMASH NM: Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25: 452-459.